Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement

Contributed by: Business Wire

Logo

Tags

Health

General Health

Research

Pharmaceutical

Science

Biotechnology

PharmaBiome

More Like This

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

PR Newswire associated0

Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science

The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions

Business Wire associated0

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

PR Newswire associated0

Crown Laboratories, Inc. and BIOJUVE® Celebrate World Microbiome Day 2024

MRM Health Initiates Clinical Research in Parkinson’s Disease

71.4% of MetaXplore™ reports from 4,616 patients identified actionable results

Microba Announces Landmark GI Study Results From Over 4,600 Patients

PR Newswire associated0

Microbiome Insights, Inc. Releases Updated Guide for Researchers Planning and Conducting Microbiome Studies